
Sign up to save your podcasts
Or


Join the experts for an in-depth update on hormone receptor (HR)-positive metastatic breast cancer (MBC).
Credit available for this activity expires: 3/1/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000254?ecd=bdc_podcast_libsyn_mscpedu
Do you know how to integrate the current evidence about Janus kinase (JAK) inhibitors?
Credit available for this activity expires: 2/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000237?ecd=bdc_podcast_libsyn_mscpedu
Do you have the most accurate information about the health risks associated with nicotine? Drs Vega and Rodu discuss.
Credit available for this activity expires: 2/27/20
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000232?ecd=bdc_podcast_libsyn_mscpedu
Myeloma experts address clinical challenges in triple-class refractory myeloma. Credit available for this activity expires: 2/20/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000082?ecd=bdc_podcast_libsyn_mscpedu
Cardiac amyloidosis is not a rare disease anymore. Do you know how to recognize the clinical presentations and red flags?
Credit available for this activity expires: 02/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000141?ecd=bdc_podcast_libsyn_mscpedu
Did you know that mutational testing helps guide treatment selection in gastrointestinal stromal tumor (GIST)? Listen to learn more! Credit available for this activity expires: 2/9/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999395?ecd=bdc_podcast_libsyn_mscpedu
The transition from pediatric to adult care should begin early. But what does that mean for patients with rare pediatric-onset epilepsies?
Credit available for this activity expires: 2/8/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000080?ecd=bdc_podcast_libsyn_mscpedu
When is the best time to use newer therapies, and what kind of adjustments do we need to make? Credit available for this activity expires: 1/24/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999797?ecd=bdc_podcast_libsyn_mscpedu
Are you up to date on the latest clinical trial and real-world data in breast cancer and how this impacts individualization of care?
Credit available for this activity expires: 1/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999668?ecd=bdc_podcast_libsyn_mscpedu
Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies.
Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu
From the publisher's feed

136 Listeners

697 Listeners

499 Listeners

163 Listeners

103 Listeners

893 Listeners

13 Listeners

16 Listeners

291 Listeners

264 Listeners

3,347 Listeners

1,158 Listeners

195 Listeners

93 Listeners

520 Listeners

371 Listeners

171 Listeners

60 Listeners

8 Listeners

430 Listeners